DeepMed Research

UNIVERSITY OF CALIFORNIA, IRVINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1965-01-01

Employees: 10K

Market Cap: -

Website: http://www.uci.edu

Clinical Trials

Dexcom G6 Continuous Glucose Monitoring in Hemodialysis

Not Applicable

Active, not recruiting

Conditions: Diabetes
Hemodialysis
Glucose Measurement

Interventions: Device: Dexcom G6 Continuous Glucose Monitor

First Posted Date: 2020-01-03

Last Posted Date: 2023-06-12

Lead Sponsor: University of California, Irvine

Target Recruit Count: 30

Registration Number: NCT04217161

Locations: 🇺🇸
University of California Irvine, Orange, California, United States

Adaptive Interventions for Optimizing Malaria Control: a Cluster-Randomized SMART Trial

Not Applicable

Completed

Conditions: LLIN, PBO LLIN, IRS, Larviciding

Interventions: Other: LLIN plus Piperonyl butoxide-treated LLIN
Other: Regular long-lasting insecticidal nets
Other: Long-lasting microbial larvicide
Other: Indoor residual spraying with micro-encapsulated pirimiphos-methyl or other insecticides

First Posted Date: 2019-12-02

Last Posted Date: 2024-10-15

Lead Sponsor: University of California, Irvine

Target Recruit Count: 122872

Registration Number: NCT04182126

Locations: 🇰🇪
Tom-Mboya University College, Maseno University, Homa Bay, Homa Bay County, Kenya
🇺🇸
Program in Public Health, Irvine, California, United States

Combined Focused Ultrasound and Calcium Hydroxylapatitie Filler for Skin Laxity and Volume Restoration

Phase 1

Completed

Conditions: Skin Laxity

Interventions: Combination Product: calcium hydroxylapatite (Radiesse) and IFUS (Ulthera)

First Posted Date: 2019-11-25

Last Posted Date: 2024-02-02

Lead Sponsor: University of California, Irvine

Target Recruit Count: 20

Registration Number: NCT04176068

Locations: 🇺🇸
University of California, Irvine Dermatology Clinical Research Center, Irvine, California, United States

Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

Phase 2

Active, not recruiting

Conditions: Gastric Adenocarcinoma
GastroEsophageal Cancer

Interventions: Drug: Cabozantinib
Drug: Pembrolizumab

First Posted Date: 2019-11-15

Last Posted Date: 2024-06-07

Lead Sponsor: University of California, Irvine

Target Recruit Count: 20

Registration Number: NCT04164979

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

A Biobehavioral Intervention for Young Men With Testicular Cancer

Phase 2

Conditions: Testis Cancer

Interventions: Behavioral: Individual Supportive Psychotherapy (ISP)
Behavioral: Goal-Focused Emotion Regulation Therapy (GET)

First Posted Date: 2019-11-05

Last Posted Date: 2020-12-19

Lead Sponsor: University of California, Irvine

Target Recruit Count: 100

Registration Number: NCT04150848

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of California, Irvine, Irvine, California, United States

TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma

Phase 1

Completed

Conditions: Gastric Adenocarcinoma
GastroEsophageal Cancer

Interventions: Drug: TAS-102
Drug: Irinotecan

First Posted Date: 2019-08-30

Last Posted Date: 2024-02-02

Lead Sponsor: University of California, Irvine

Target Recruit Count: 20

Registration Number: NCT04074343

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States
🇺🇸
UC Davis Comprehensive Cancer Center, Sacramento, California, United States

Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

Phase 2

Terminated

Conditions: Carcinoma, Transitional Cell

Interventions: Drug: Oxaliplatin with Gemcitabine

First Posted Date: 2019-07-31

Last Posted Date: 2023-08-21

Lead Sponsor: University of California, Irvine

Target Recruit Count: 17

Registration Number: NCT04039867

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

Not Applicable

Recruiting

Conditions: Hypothyroidism
Hemodialysis
Thyroid; Functional Disturbance

Interventions: Drug: Placebos
Drug: Levothyroxine Sodium

First Posted Date: 2019-06-06

Last Posted Date: 2024-02-29

Lead Sponsor: University of California, Irvine

Target Recruit Count: 336

Registration Number: NCT03977207

Locations: 🇺🇸
University of California Irvine, Orange, California, United States

Study Of Drinks With Artificial Sweeteners in People With Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Behavioral: Diet Beverage
Behavioral: Water

First Posted Date: 2019-05-09

Last Posted Date: 2024-06-12

Lead Sponsor: University of California, Irvine

Target Recruit Count: 181

Registration Number: NCT03944616

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
University of California, Irvine, Irvine, California, United States

Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ

Phase 2

Active, not recruiting

Conditions: Glioma of Brain

Interventions: Drug: Mirtazapine (Remeron)

First Posted Date: 2019-05-02

Last Posted Date: 2024-05-14

Lead Sponsor: University of California, Irvine

Target Recruit Count: 120

Registration Number: NCT03935685

Locations: 🇺🇸
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy